Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?

To: John Carragher who wrote (511)	1/28/1999 8:37:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 942

Buy/strong buy reiterations: On 1/27 Bear Stearns reiterated buy, Lehman Brothers reiterated strong buy; on 1/25 and 26 five brokerages reiterate buy and strong buy, list at nordby.com Merrill Lynch also reiterated buy, short and long term on 1/26. No target given.

To: John Carragher who wrote (511)	1/28/1999 9:27:00 AM
From: Anthony Wong	Respond to of 942

WLA options activity yesterday: Elsewhere on the AMEX, traders noted heavy selling of April 65 puts on Warner Lambert Co. (NYSE:WLA - news) after the drug company said it would buy biotech concern Agouron Pharmaceuticals Inc. (Nasdaq:AGPH - news), known for its AIDS treatment Viracept. ''Put selling is usually a bullish transaction,'' Schwartz said. ''It's an attractive way to own the stock below the market.'' Warner Lambert stock climbed 3-5/8 to 72-1/8. U.S. OPTIONS Wednesday January 27, 10:00 pm Eastern Time biz.yahoo.com